Eli Lilly & Co.
LLY XNYS
$953.30
+1.70 (+0.18%)
▲
15-min delayed
Open
N/A
High
N/A
Low
N/A
Volume
N/A
Market Cap
$851.64B
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| TTM 2025 | $65.18B | $20.64B | $23.00 |
| FY 2025 | $65.18B | $20.64B | $23.00 |
| Q3 2025 | $17.60B | $5.58B | $6.22 |
| Q2 2025 | $15.56B | $5.66B | $6.30 |
TickerDaily Coverage
Why Are These 5 Stocks Making Biggest Pre-Market Moves Today? April 7, 2026
Market News
Sarah Mitchell · 2d ago
Tuesday's pre-market session is already volatile. Five major stocks are moving significantly on...
Why Are These 5 Stocks Making Biggest Pre-Market Moves Today? April 8, 2026
Market News
Sarah Mitchell · 1d ago
Five major stocks are trading significantly higher and lower in pre-market action Wednesday...
Healthcare Stocks This Week: XLV Ends Mixed as Pharma Giants Face Margin Pressures (Mar 23–27, 2026)
Market News
David Brooks · Mar 27, 2026
The healthcare sector finished Friday, March 27, 2026 in neutral territory as investor focus...
Why Are These Top Stocks Up and Down Before the Bell Today? March 24, 2026 Pre-Market Movers
Market News
Sarah Mitchell · Mar 24, 2026
Five major stocks are making significant moves in pre-market trading on Tuesday, March 24, 2026,...
Why Are These Stocks Making the Biggest Pre-Market Moves Today? March 19, 2026
Market News
Sarah Mitchell · Mar 19, 2026
Five stocks are printing outsized moves in pre-market trading Thursday, March 19, 2026, driven by...
View All Coverage →
Get LLY Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Eli Lilly & Co..
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.